Benitec Biopharma Ltd is a biotechnology company focused on developing innovative therapeutics leveraging its proprietary DNA-directed RNA interference platform

The company's research aims to address a range of genetic diseases and cancers by utilizing gene silencing technology to inhibit the expression of disease-causing genes. Benitec's approach involves creating treatments that can target specific genetic sequences, thereby offering the potential for durable and long-lasting therapeutic effects. Through its pipeline of drug candidates, Benitec seeks to advance the field of genetic medicine and improve patient outcomes.